Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2010-11-10 17:40:00

NEW YORK, Nov. 10, 2010 /PRNewswire/ -- Aspirin comes to the rescue again, as a potential prostate cancer treatment option. A new study presented at the American Society for Radiation Oncology (ASTRO) in San Diego, shows that it may cut the risk of dying for men with prostate cancer that has not spread beyond the prostate gland. "The study showed that prostate cancer patients taking blood thinning, or anticoagulant medication, specifically aspirin, had a lower risk of mortality, more so in...

2010-11-01 22:37:52

Nonsteroidal anti-inflammatory drugs (NSAIDs) prevent colon cancer by triggering diseased stem cells to self-destruct, according to researchers at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine. Their findings, reported in the early online version of this week's Proceedings of the National Academy of Sciences, could lead to new strategies to protect people at high risk for the disease. Doctors have long known that NSAIDs, such as...

2010-10-26 07:30:00

BEDMINSTER, N.J., Oct. 26 /PRNewswire/ -- Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, announced today that an analysis of two pivotal safety and efficacy studies of CAMBIA(TM) (diclofenac potassium for oral solution) will be presented at the 4th World Congress on Controversies in Neurology Conference (CONy) in Barcelona, Spain. The new analysis will be presented in a poster (#23) entitled, "Rapid and Sustained Improvement in Migraine Symptoms with a...

ebdedcb4a1c30ddeb29f3174c5341d871
2010-10-22 09:15:00

The same low dose aspirin recommended by doctors to lower the risk of heart attack and stroke can also help combat colon cancer, according to new researched published Friday in The Lancet. An international team of researchers, led by Oxford University Professor Peter M. Rothwell, conducted a series of four randomized trials over a total period of 20 years. Each of the studies lasted an average of six years and involved a total of more than 14,000 patients, who either took a placebo or one of...

2010-10-07 14:17:00

NASHVILLE, Tenn., Oct. 7 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of data affirming the safety and efficacy of Caldolor® (ibuprofen) Injection in treating fever in critically ill and non-critically ill adults. Published in the peer-reviewed journal Critical Care, the study showed that IV ibuprofen was significantly more effective at reducing fever in hospitalized patients than placebo. "These findings demonstrate...

2010-10-06 09:23:00

NEW YORK, Oct. 6 /PRNewswire/ -- For Joy Behar - comedienne, television host, author and mother - heart disease is a family affair. Despite having lost both parents to heart disease, Joy's mother Rose was not prepared when a sudden heart attack struck in her fifties. Now, Joy and her daughter, Eve, are challenging women who have or are at risk for heart disease to be prepared and better their odds of surviving should a heart attack strike without warning. And they caution women, "don't...

2010-10-04 13:01:00

MADISON, N.J., Oct. 4 /PRNewswire-FirstCall/ -- Pfizer Consumer Healthcare, maker of Advil® pain-relief products, announced today the launch of a consumer campaign encouraging Americans to clean out their medicine cabinets and properly dispose of unwanted, expired and recalled products. A recent poll shows that nearly half of Americans do not always look at the expiration date on over-the-counter medications before taking them.(1) (Photo:...

2010-10-04 08:00:00

SEOUL, South Korea, Oct. 4 /PRNewswire/ -- CrystalGenomics, Inc. (Seoul, Korea) and CG Pharmaceuticals, Inc. (Emeryville, California), a drug discovery and development biopharmaceutical company, has announced that Dr. William Schmidt, its Vice President of Clinical Development, has been invited to present a talk on "Development of CG100649, Tissue-selective Dual Inhibitor of COX-2 and Carbonic Anhydrase for Treatment of Osteoarthritis" at Arrowhead's upcoming 4th Annual Pain Therapeutics...

2010-09-20 23:20:51

A new study shows that aspirin, given intravenously (IV), may be a safe and effective option for people hospitalized for severe headache or migraine, undergoing medication withdrawal. The research will be published in the September 21, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology. "Intravenous aspirin is not readily available in the United States and only on a 'named patient' basis in the United Kingdom, while it is more generally used...

2010-09-16 13:03:01

Effect of aspirin and NSAIDS on risk and survival from colorectal cancer Even the lowest possible dose of aspirin (75 mg) can ward off bowel cancer, if taken regularly, finds research published online in the journal Gut. This protective effect is apparent after just one year and in the general population, not just those considered to be at risk of developing the disease, which is the second most common cause of cancer death in the world, killing almost half a million people every year....


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.